Last €95.64 EUR
Change Today +1.19 / 1.26%
Volume 0.0
IX1 On Other Exchanges
As of 3:44 AM 10/2/14 All times are local (Market data is delayed by at least 15 minutes).

idexx laboratories inc (IX1) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/7/14 - €100.18
52 Week Low
12/13/13 - €73.30
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IDEXX LABORATORIES INC (IX1)

idexx laboratories inc (IX1) Related Bloomberg News

View More Bloomberg News

idexx laboratories inc (IX1) Related Businessweek News

No Related Businessweek News Found

idexx laboratories inc (IX1) Details

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. The company operates through Companion Animal Group, Water, Livestock and Poultry Diagnostics, Dairy, and OPTI Medical segments. The company primary offers point-of-care veterinary diagnostic products comprising instruments and consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; and practice management systems and services, and digital radiography systems used by veterinarians. It also provides biological materials testing and laboratory diagnostic instruments and services used by the biomedical research community; diagnostic and health-monitoring products for livestock and poultry; products that test water for certain microbiological contaminants; products that test milk for antibiotic residues and other contaminants; and point-of-care electrolytes and blood gas analyzers used in the human point-of-care medical diagnostics market. The company markets and sells its products through marketing, sales, and technical service groups, as well as independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

5,700 Employees
Last Reported Date: 02/18/14
Founded in 1983

idexx laboratories inc (IX1) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $784.6K
Executive Vice President
Total Annual Compensation: $396.2K
Executive Vice President
Total Annual Compensation: $396.2K
Executive Vice President
Total Annual Compensation: $396.2K
Vice President of Finance
Total Annual Compensation: $300.0K
Compensation as of Fiscal Year 2013.

idexx laboratories inc (IX1) Key Developments

IDEXX Laboratories Names Jacqueline L. Studer as Corporate Vice President and General Counsel

IDEXX Laboratories, Inc. announced the appointment of Jacqueline L. Studer as Corporate Vice President, General Counsel and Secretary, effective September 1. Ms. Studer leads the Legal, Compliance, Regulatory Affairs and Quality Assurance groups. Prior to joining IDEXX in June of this year, Studer was General Counsel at Blue Health Intelligence, a healthcare data and analytics company. Previously, she served as General Counsel at Allscripts Healthcare Solutions, a publicly traded healthcare IT company, and in several leadership positions at GE Healthcare, a medical technology company, including as General Counsel of the GE Healthcare IT and Performance Solutions division. She has extensive experience in building and leading legal organizations to support high-growth technology companies.

IDEXX Laboratories, Inc. Unveils Two New Itchy Pet Diagnostic Tests

IDEXX Laboratories, Inc. has unveiled two new tests, IDEXX Sarcoptes Antibody ELISA and IDEXX Ringworm RealPCR Panel, to aid veterinarians in the diagnosis and management of itchy pets. Veterinarians are now able to submit specimens to IDEXX Reference Laboratories for the Sarcoptes Antibody ELISA and the Ringworm RealPCR Panel. The Sarcoptes Antibody ELISA is used to confirm or rule out a suspicion of sarcoptic mange in dogs based on clinical signs. The condition is currently diagnosed by skin scraping but most often confirmed through response to treatment. The Ringworm RealPCR Panel uses real-time PCR technology to accurately detect dermatophytosis in cats and dogs faster, providing reliable results in 1-3 working days versus weeks using traditional methods, such as the dermatophyte test media (DTM) plate or fungal culture. These tests expand and complement a comprehensive portfolio of products from IDEXX that facilitate the diagnosis and management of itch. For patients diagnosed with allergies, IDEXX offers a low-cost test to identify what allergen groups are causing a pet's reaction and to confirm if a pet is a good candidate for immunotherapy using the Aller-g-complete system.

IDEXX Laboratories Announces New LEED(R) Gold Corporate Headquarters

IDEXX Laboratories has officially taken occupancy of its new $35 million Synergy Center. The Westbrook, Maine headquarters campus now offers more than 750,000 square feet of office and laboratory space, plus an international food court and wellness center, all 'Under One Roof'. IDEXX made its design objectives for the new 108,000 square foot building clear from the start. The first was to create increased opportunities for IDEXX employees to collaborate, allowing for cross-pollination of ideas across multiple disciplines. Lavallee Brensinger's design response included the strategic placement of meeting spaces, food, and wellness center all at the core of the new building's primary circulation. This core is integrated into the campus' existing circulation as the major crossroads, engaging IDEXX's more than 2,100 on-site employees daily. A second imperative was to capture the dynamic spirit of IDEXX through the development of flexible, readily adaptable spaces.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IX1:GR €95.64 EUR +1.19

IX1 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DENTSPLY International Inc $45.31 USD -0.29
Hologic Inc $23.84 USD -0.49
MEDNAX Inc $53.69 USD -1.13
ResMed Inc $49.50 USD +0.23
Siemens Ltd 818.05 INR 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation IX1 Industry Range
Price/Earnings 32.1x
Price/Sales 4.2x
Price/Book 13.1x
Price/Cash Flow 30.7x
TEV/Sales 3.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDEXX LABORATORIES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at